Biotech Top Losers: Geron Corporation (NASDAQ:GERN), Synta Pharmaceuticals (NASDAQ:SNTA), Northwest Biotherapeutics (NASDAQ:NWBO), AEterna Zentaris (NASDAQ:AEZS)

Geron Corporation (NASDAQ:GERN) said the US Food and Drug Administration ordered a halt to trials of a cancer drug over concerns about potential liver damage. Geron Corporation (NASDAQ:GERN) stock performance was -61.59% in last session and finished the day at $1.69. Traded volume was 46,444,384 million shares in the last session and the average volume of the stock remained 4.64 million shares. The beta of … Continue reading Biotech Top Losers: Geron Corporation (NASDAQ:GERN), Synta Pharmaceuticals (NASDAQ:SNTA), Northwest Biotherapeutics (NASDAQ:NWBO), AEterna Zentaris (NASDAQ:AEZS)

Biotech Unusual Volume: Northwest Biotherapeutics (NASDAQ:NWBO), La Jolla Pharmaceutical Company (NASDAQ:LJPC), OXiGENE (NASDAQ:OXGN), Tengion (OTCMKTS:TNGN)

Northwest Biotherapeutics Inc (NASDAQ:NWBO) a biotechnology company developing DCVax personalized immune therapies for solid tumour cancers, has received approval from the Paul Ehrlich Institute (PEI- the FDA of Germany) of a “Hospital Exemption” early access programme under Section 4b of the German Drug Law. Northwest Biotherapeutics, Inc (NASDAQ:NWBO) stock performance was 16.93% in last session and finished the day at $9.18. Traded volume was 8,391,894 … Continue reading Biotech Unusual Volume: Northwest Biotherapeutics (NASDAQ:NWBO), La Jolla Pharmaceutical Company (NASDAQ:LJPC), OXiGENE (NASDAQ:OXGN), Tengion (OTCMKTS:TNGN)

Biotech Most Active Stocks: Inovio Pharmaceuticals (NYSEMKT:INO), Northwest Biotherapeutics (NASDAQ:NWBO), Peregrine Pharmaceuticals (NASDAQ:PPHM), MannKind (NASDAQ:MNKD)

Inovio Pharmaceuticals, Inc. (AMEX:INO) entered into an office lease (the “Lease”) with a publicly owned real estate investment trust, located in Plymouth Meeting, Pennsylvania. We expect to occupy the space commencing in the third quarter of 2014. The initial term of the lease is eleven and one-half years. We intend to use the facility for office purposes. Inovio Pharmaceuticals Inc (NYSEMKT:INO) stock performance was 3.53% … Continue reading Biotech Most Active Stocks: Inovio Pharmaceuticals (NYSEMKT:INO), Northwest Biotherapeutics (NASDAQ:NWBO), Peregrine Pharmaceuticals (NASDAQ:PPHM), MannKind (NASDAQ:MNKD)

Biotech Stocks Touching New Highs: Northwest Biotherapeutics (NASDAQ:NWBO), OncoGenex Pharmaceuticals (NASDAQ:OGXI), Emergent Biosolutions (NYSE:EBS), Xencor (NASDAQ:XNCR)

CRT Capital Thursday morning ratings report included a coverage initiation by analyst Arlinda Lee on Oncogenex Pharmaceuticals (NASDAQ: OGXI) with a Buy rating and price target of $20. OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI) rose 8.88 percent to $13.85 yesterday on volume of 483,342million shares. The intra-day range of the stock was $12.61 to $13.95. OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI) has a market capitalization of $203.70million. Emergent Biosolutions … Continue reading Biotech Stocks Touching New Highs: Northwest Biotherapeutics (NASDAQ:NWBO), OncoGenex Pharmaceuticals (NASDAQ:OGXI), Emergent Biosolutions (NYSE:EBS), Xencor (NASDAQ:XNCR)

Biotech Top Gainers: Northwest Biotherapeutics (NASDAQ:NWBO), Alexion Pharmaceuticals (NASDAQ:ALXN), Merrimack Pharmaceuticals (NASDAQ:MACK), Enzon Pharmaceuticals (NASDAQ:ENZN)

German health regulators have granted Northwest Biotherapeutics Inc (NASDAQ:NWBO) special permission to sell its experimental brain cancer drug, DCVax-L, in the country, even though the small US biotechnology company has not yet completed its late-stage trial of the immunotherapy. Northwest Biotherapeutics, Inc (NASDAQ:NWBO) stock performance was 29.55% in last session and finished the day at $7.85. Traded volume was 6,155,092 million shares in the last … Continue reading Biotech Top Gainers: Northwest Biotherapeutics (NASDAQ:NWBO), Alexion Pharmaceuticals (NASDAQ:ALXN), Merrimack Pharmaceuticals (NASDAQ:MACK), Enzon Pharmaceuticals (NASDAQ:ENZN)

Pre-Market Noise Makers: Northwest Biotherapeutics (NASDAQ:NWBO), Children’s Place (NASDAQ:PLCE), Cooper Companies (NYSE:COO), Verisk Analytics (NASDAQ:VRSK)

Shares in Northwest Biotherapeutics (NASDAQ:NWBO), a biotechnology company developing DCVax personalized immune therapies for solid tumor cancers, have jumped 12% pre-market after the company said the Data Safety Monitoring Board has recommended its Phase III trial into a lethal form of brain cancer continue. The company’s lead program is a 312-patient Phase III trial in newly diagnosed Glioblastoma multiforme (GBM). Northwest Biotherapeutics (NASDAQ:NWBO)’s stock on … Continue reading Pre-Market Noise Makers: Northwest Biotherapeutics (NASDAQ:NWBO), Children’s Place (NASDAQ:PLCE), Cooper Companies (NYSE:COO), Verisk Analytics (NASDAQ:VRSK)